This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1993-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Muttenz, CH (1993)
- Therwil, CH (2004 - 2005)
Company Filing History:
Years Active: 1993-2005
Title: Pierre Charles Wyss: Innovator in Pharmaceutical Chemistry
Introduction
Pierre Charles Wyss is a notable inventor based in Therwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases.
Latest Patents
Wyss holds three patents, with his latest focusing on Pyrido[2,1-a]isoquinoline derivatives. This invention provides compounds of a specific formula, which are useful for the treatment and/or prophylaxis of diseases associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance. The compounds also include pharmaceutically acceptable salts, enhancing their applicability in medical treatments.
Career Highlights
Wyss is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has been instrumental in advancing therapeutic options for patients suffering from metabolic disorders.
Collaborations
Throughout his career, Wyss has collaborated with esteemed colleagues, including Luca Claudio Gobbi and Thomas Luebbers. These partnerships have fostered innovation and contributed to the successful development of new pharmaceutical compounds.
Conclusion
Pierre Charles Wyss exemplifies the spirit of innovation in pharmaceutical chemistry, with his patents paving the way for advancements in diabetes treatment. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile